We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $14.6B
1-Year Est. Return 40.95%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+40.95%
3 Year Est. Return
+104.32%
5 Year Est. Return
+50.55%
10 Year Est. Return
+495.11%
AUM
$16.7B
AUM Growth
+$2.72B
Cap. Flow
+$2.51B
Cap. Flow %
15.03%
Top 10 Hldgs %
35.19%
Holding
1,938
New
561
Increased
410
Reduced
355
Closed
390

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$349M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$323M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$311M
4
MSFT icon
Microsoft
MSFT
+$264M
5
WYNN icon
Wynn Resorts
WYNN
+$155M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$309M
2
NXPI icon
NXP Semiconductors
NXPI
+$122M
3
NVDA icon
NVIDIA
NVDA
+$97.7M
4
AMGN icon
Amgen
AMGN
+$79M
5
SHEL icon
Shell
SHEL
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 8.51%
2 Technology 8.13%
3 Consumer Discretionary 5.54%
4 Financials 4.12%
5 Communication Services 3.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQT icon
51
EQT Corp
EQT
$32.5B
$61M 0.37%
1,322,992
-360,202
-21% -$14.9M
CLDX icon
52
Celldex Therapeutics
CLDX
$2.8B
$60.4M 0.36%
2,390,398
+2,369,398
+11,283% +$64.4M
CRWD icon
53
PUT
CrowdStrike
CRWD
$183B
$60M 0.36%
702,000
+594,400
+552% +$49.4M
PRGS icon
54
PUT
Progress Software
PRGS
$1.59B
$58.6M 0.35%
900,000
+896,400
+24,900% +$59.9M
CCC
55
CCC Intelligent Solutions
CCC
$3.5B
$58.1M 0.35%
+4,951,387
New +$57.3M
PTGX icon
56
Protagonist Therapeutics
PTGX
$8.72B
$57.5M 0.34%
1,489,495
-325,201
-18% -$14.2M
XBI icon
57
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$55M 0.33%
610,733
+541,290
+779% +$52.4M
BRK.B icon
58
Berkshire Hathaway Class B
BRK.B
$1.07T
$50.4M 0.3%
111,223
+110,231
+11,112% +$50.9M
GOOG icon
59
Alphabet (Google) Class C
GOOG
$3.99T
$50.2M 0.3%
263,610
+246,470
+1,438% +$43.5M
BRK.B icon
60
PUT
Berkshire Hathaway Class B
BRK.B
$1.07T
$49.9M 0.3%
+110,000
New +$50.8M
AGIO icon
61
Agios Pharmaceuticals
AGIO
$2.2B
$49.3M 0.3%
+1,500,000
New +$70.5M
CXM icon
62
Sprinklr
CXM
$1.42B
$49.1M 0.29%
5,807,400
+2,851,106
+96% +$22.8M
BIDU icon
63
CALL
Baidu
BIDU
$35.8B
$47.5M 0.28%
+563,400
New +$51.4M
CZR icon
64
Caesars Entertainment
CZR
$6.1B
$46.4M 0.28%
1,388,067
+1,351,286
+3,674% +$53.5M
AMD icon
65
PUT
Advanced Micro Devices
AMD
$807B
$45.9M 0.27%
380,000
+286,700
+307% +$41.3M
TGI
66
DELISTED
Triumph Group
TGI
$45.5M 0.27%
2,437,013
+538
+0% +$8.94K
AR icon
67
Antero Resources
AR
$10.5B
$44.3M 0.26%
1,262,605
-268,648
-18% -$8.13M
PRGS icon
68
Progress Software
PRGS
$1.59B
$44.1M 0.26%
676,835
+662,881
+4,750% +$44.3M
CCI icon
69
Crown Castle
CCI
$32.4B
$43.6M 0.26%
480,030
+476,556
+13,718% +$49.8M
MSTR icon
70
PUT
Strategy Inc
MSTR
$36B
$43.4M 0.26%
150,000
-20,000
-12% -$6.02M
USB icon
71
US Bancorp
USB
$98.9B
$43.2M 0.26%
903,622
+893,286
+8,642% +$43.9M
EMB icon
72
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$42.8M 0.26%
480,179
+390,000
+432% +$35.6M
ZIM icon
73
PUT
ZIM Integrated Shipping Services
ZIM
$2.96B
$42.6M 0.25%
1,983,400
+132,000
+7% +$2.9M
JPM icon
74
PUT
JPMorgan Chase
JPM
$947B
$42.5M 0.25%
177,300
+46,700
+36% +$10.9M
DYN icon
75
Dyne Therapeutics
DYN
$4.24B
$42.4M 0.25%
+1,800,000
New +$53.2M
1 2
3
4 5

Similar funds

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Jefferies Financial Group's Q4 2024 Portfolio in Review

As of Q4 2024, Jefferies Financial Group held 1,938 positions worth $16.7B, up 19% from $14B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Jefferies Financial Group deployed $2.51B of net new capital in Q4 2024, opening 561 new positions and adding to 410 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,500,000 shares worth $49.3M.

By sector, the portfolio is most concentrated in Healthcare at 8.5% of assets, down from 9.8% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $309M trimmed.

  • Jefferies Financial Group's largest Q4 2024 buy was Agios Pharmaceuticals: 1,500,000 shares worth $49.3M.
  • Jefferies Financial Group added most to Amazon in Q4 2024, an estimated $349M increase.
  • Jefferies Financial Group's biggest Q4 2024 reduction was Apple, cutting an estimated $309M.
  • Jefferies Financial Group fully exited Kellanova in Q4 2024, selling an estimated $23.2M.
  • Jefferies Financial Group's ten largest holdings make up 35% of its $16.7B portfolio in Q4 2024.
  • Jefferies Financial Group opened 561 new positions and closed 390 in Q4 2024.
  • Jefferies Financial Group's portfolio value rose 19% quarter-over-quarter to $16.7B.

Based on Jefferies Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.